96 related articles for article (PubMed ID: 2914841)
1. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.
Perry R; Campbell M; Adams P; Lynch N; Spencer EK; Curren EL; Overall JE
J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):87-92. PubMed ID: 2914841
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol withdrawal and weight changes in autistic children.
Silva RR; Malone RP; Anderson LT; Shay J; Campbell M
Psychopharmacol Bull; 1993; 29(2):287-91. PubMed ID: 8290679
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.
Campbell M; Armenteros JL; Malone RP; Adams PB; Eisenberg ZW; Overall JE
J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):835-43. PubMed ID: 9183140
[TBL] [Abstract][Full Text] [Related]
4. Factors related to haloperidol response and dyskinesias in autistic children.
Locascio JJ; Malone RP; Small AM; Kafantaris V; Ernst M; Lynch NS; Overall JE; Campbell M
Psychopharmacol Bull; 1991; 27(2):119-26. PubMed ID: 1924657
[TBL] [Abstract][Full Text] [Related]
5. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-related dyskinesias in autistic children: a prospective study.
Perry R; Campbell M; Green WH; Small AM; Die Trill ML; Meiselas K; Golden RR; Deutsch SI
Psychopharmacol Bull; 1985; 21(1):140-3. PubMed ID: 3885290
[No Abstract] [Full Text] [Related]
7. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
[TBL] [Abstract][Full Text] [Related]
8. Tourette-like symptoms associated with neuroleptic therapy in an autistic child.
Perry R; Nobler MS; Campbell M
J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):93-6. PubMed ID: 2914842
[TBL] [Abstract][Full Text] [Related]
9. Repeated episodes of neuroleptic-related dyskinesias in autistic children.
Malone RP; Ernst M; Godfrey KA; Locascio JJ; Campbell M
Psychopharmacol Bull; 1991; 27(2):113-7. PubMed ID: 1681562
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.
Armenteros JL; Adams PB; Campbell M; Eisenberg ZW
Psychopharmacol Bull; 1995; 31(2):363-9. PubMed ID: 7491393
[TBL] [Abstract][Full Text] [Related]
11. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
Ernst M; Devi L; Silva RR; Gonzalez NM; Small AM; Malone RP; Campbell M
Psychopharmacol Bull; 1993; 29(2):221-7. PubMed ID: 8290669
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.
Meiselas KD; Spencer EK; Oberfield R; Peselow ED; Angrist B; Campbell M
J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463
[TBL] [Abstract][Full Text] [Related]
13. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
[TBL] [Abstract][Full Text] [Related]
14. Effects of small doses of haloperidol on autistic children.
Hoshino Y; Yashima Y; Ishige K; Kaneko M; Kumashiro H
Fukushima J Med Sci; 1979; 26(1-2):43-54. PubMed ID: 521004
[No Abstract] [Full Text] [Related]
15. Stereotypies and tardive dyskinesia: abnormal movements in autistic children.
Campbell M; Locascio JJ; Choroco MC; Spencer EK; Malone RP; Kafantaris V; Overall JE
Psychopharmacol Bull; 1990; 26(2):260-6. PubMed ID: 2236468
[TBL] [Abstract][Full Text] [Related]
16. Should autistic children be treated with haloperidol?
Ornitz EM
Am J Psychiatry; 1985 Jul; 142(7):883-4. PubMed ID: 3893168
[No Abstract] [Full Text] [Related]
17. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
18. [Psychopharmacology of autism].
Chabrol H; Bonnet D; Roge B
Encephale; 1996; 22(3):197-203. PubMed ID: 8767048
[TBL] [Abstract][Full Text] [Related]
19. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
[TBL] [Abstract][Full Text] [Related]
20. Pimozide in autistic children.
Ernst M; Magee HJ; Gonzalez NM; Locascio JJ; Rosenberg CR; Campbell M
Psychopharmacol Bull; 1992; 28(2):187-91. PubMed ID: 1513923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
